Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.

Pfaar, O; Klimek, L; Fischer, I; Sieber, J; Amoroso, S; Moreno Aguilar, C; Shah, K; Mösges, R

Pfaar, O; Klimek, L; Fischer, I; Sieber, J; Amoroso, S; Moreno Aguilar, C; Shah, K; Mösges, R.

Affiliation

Pfaar O; Center for Rhinology and Allergology Wiesbaden, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, An den Quellen 10, Wiesbaden DE-65189, Germany. oliver.pfaar@hno-wiesbaden.de

Int Arch Allergy Immunol ; 150(1): 102-8, 2009.

Article in En | MEDLINE | ID: mdl-19339808

Subject(s)

Allergens/administration & dosage; Asthma/prevention & control; Desensitization, Immunologic/methods; Rhinitis, Allergic, Seasonal/prevention & control; Adolescent; Adult; Allergens/immunology; Animals; Desensitization, Immunologic/adverse effects; Female; Humans; Male; Middle Aged; Pollen/immunology; Pyroglyphidae/immunology; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Allergens / Rhinitis, Allergic, Seasonal / Desensitization, Immunologic Type of study: Clinical_trials Limits: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: Int Arch Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2009 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google